Louisiana State Employees Retirement System Has $2.73 Million Position in Merit Medical Systems, Inc. (NASDAQ:MMSI)

Louisiana State Employees Retirement System raised its stake in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 0.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 28,200 shares of the medical instruments supplier’s stock after buying an additional 100 shares during the quarter. Louisiana State Employees Retirement System’s holdings in Merit Medical Systems were worth $2,728,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Farther Finance Advisors LLC lifted its holdings in shares of Merit Medical Systems by 32.7% during the 3rd quarter. Farther Finance Advisors LLC now owns 1,056 shares of the medical instruments supplier’s stock valued at $104,000 after purchasing an additional 260 shares in the last quarter. Harvest Fund Management Co. Ltd bought a new position in shares of Merit Medical Systems during the 3rd quarter valued at about $120,000. GAMMA Investing LLC lifted its holdings in shares of Merit Medical Systems by 14.7% during the 4th quarter. GAMMA Investing LLC now owns 1,494 shares of the medical instruments supplier’s stock valued at $144,000 after purchasing an additional 191 shares in the last quarter. TD Private Client Wealth LLC lifted its holdings in shares of Merit Medical Systems by 13.9% during the 3rd quarter. TD Private Client Wealth LLC now owns 1,732 shares of the medical instruments supplier’s stock valued at $171,000 after purchasing an additional 211 shares in the last quarter. Finally, Ballentine Partners LLC bought a new position in shares of Merit Medical Systems during the 4th quarter valued at about $200,000. Institutional investors own 99.66% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on MMSI shares. Wells Fargo & Company upgraded Merit Medical Systems from an “equal weight” rating to an “overweight” rating and lifted their price objective for the company from $103.00 to $120.00 in a report on Wednesday, December 11th. Robert W. Baird boosted their target price on Merit Medical Systems from $107.00 to $109.00 and gave the company an “outperform” rating in a research note on Thursday, October 31st. Raymond James boosted their target price on Merit Medical Systems from $105.00 to $110.00 and gave the company an “outperform” rating in a research note on Tuesday, December 31st. Piper Sandler restated an “overweight” rating and issued a $116.00 target price (up previously from $114.00) on shares of Merit Medical Systems in a research note on Wednesday, January 29th. Finally, StockNews.com cut Merit Medical Systems from a “buy” rating to a “hold” rating in a research note on Sunday, November 3rd. Two analysts have rated the stock with a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $109.80.

Merit Medical Systems Stock Up 0.6 %

NASDAQ:MMSI opened at $108.36 on Friday. The firm has a market capitalization of $6.32 billion, a price-to-earnings ratio of 53.12, a price-to-earnings-growth ratio of 2.42 and a beta of 0.87. Merit Medical Systems, Inc. has a twelve month low of $70.70 and a twelve month high of $111.45. The stock’s 50 day moving average price is $102.21 and its two-hundred day moving average price is $98.64. The company has a quick ratio of 3.82, a current ratio of 5.36 and a debt-to-equity ratio of 0.57.

Merit Medical Systems Profile

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.